- Home
- Member Resources
- Podcasts
- Lung Cancer
-
The biomarker testing landscape is evolving quickly, as is its impact on patient care, and pathologists need to keep current on the field, explains Jeff Chang, MD, FCAP, in this CAPcast interview.